I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children
Study of adding anti-CD20 antibody (rituximab) with chemotherapy: CD20 is found to be expressed in 40-50% of B-lineage ALL, and rituximab has been studied in adult ALL with superior survival (75% vs 47%,). There is little experience of using rituximab in pediatric ALL thus a CCCG Relapsed ALL 2017 Study …
leukemic cells
testicular
remission
bortezomib injection
acute lymphoblastic leukemia
- 0 views
- 16 Feb, 2024
- 1 location
Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL
The hematologic recurrence rate of MRD-positive patients with adult ALL is high. MRD- is associated with better prognosis. Therefore, maintaining MRD- after transplantation is necessary for long-term survival.
- 0 views
- 12 Jul, 2023
- 2 locations